(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

SERELYS

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

SERELYS

ST13

US500000079325720

Class

5, 29

Filing

79325720

Registration

6988004

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

01/10/2025

Trademark type

Word

Nice classes

5, 29

Filing date

08/02/2021

Registration date

02/28/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/28/2023

Last transaction

01/10/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

98

Owner location

MC

Examiner

RODRIGUEZ FONTANE, KIARA

Law office

T70

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

S. P. (pessoa física)
S.A.R.L. AXEEN PHARMA
S. P. (pessoa física)

Representatives

Clifford D. Hyra Fresh IP PLC

Technical classification

Nice Classes

Class 5Class 29

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for the treatment of hot flashesbladder functioningimmune systemfatiguenervousnesspremenstrual and menstrual painbone problemsheart problems and vitality problemsdiscomfort during perimenopause and menopause; food supplements; nutritional supplements; dietetic substances adapted for medical usedietetic preparations adapted for medical purposes; food supplements for human consumption in the form of tablets and capsules; pharmaceutical products for the treatment of hot flashesbladder functioningimmune systemfatiguenervousnesspremenstrual and menstrual painbone problemsheart problems and vitality problemsdiscomfort during perimenopause and menopause for human use in the form of tablets and capsules; pollen extracts and plant extracts sold as components of food supplements and pharmaceutical preparations for the treatment of hot flashesbladder functioningimmune systemfatiguenervousnesspremenstrual and menstrual painbone problemsheart problems and vitality problemsdiscomfort during perimenopause and menopause; pollen dietary supplements and pollen dietary supplements in the form of pollen extracts for medicalpharmaceutical or nutritional use

Class 29

Pollen prepared as foodstuff

Publications

History of USPTO decisions and trademark events.

31 publications found

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

11/28/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

07/26/2023

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

06/01/2023

XXCR

GENERIC MADRID TRANSACTION CREATED

06/01/2023

CHLD

CHANGE OF OWNER RECEIVED FROM IB

05/28/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

05/28/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/28/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

02/28/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/23/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

12/23/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/23/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/23/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

12/13/2022

PUBO

PUBLISHED FOR OPPOSITION

12/13/2022

GPNX

NOTIFICATION PROCESSED BY IB

12/12/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

11/23/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

11/23/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/23/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

11/07/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/03/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/02/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/02/2022

RFNT

REFUSAL PROCESSED BY IB

07/05/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

06/11/2022

RFRR

REFUSAL PROCESSED BY MPU

06/11/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

05/07/2022

CNRT

NON-FINAL ACTION WRITTEN

05/06/2022

DOCK

ASSIGNED TO EXAMINER

04/29/2022

MAFR

APPLICATION FILING RECEIPT MAILED

11/23/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/19/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/18/2021

Continuous trademark protection

Get notified about every new filing that threatens SERELYS or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.